Skip to Content

Calamos High Income Opportunities I CIHYX

Medalist Rating as of | See Calamos Investment Hub
  • NAV / 1-Day Return 7.68  /  0.00
  • Total Assets 35.5 Mil
  • Adj. Expense Ratio
    0.750%
  • Expense Ratio 0.750%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category High Yield Bond
  • Credit Quality / Interest Rate Sensitivity Low/Limited
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 6.69%
  • Effective Duration 2.81 years

USD | NAV as of May 17, 2024 | 1-Day Return as of May 17, 2024, 10:12 PM GMT+0

Morningstar’s Analysis CIHYX

Will CIHYX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Calamos High Income Opportunities I's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CIHYX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 5.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Usd

2.84 1.0 Mil
Cash and Equivalents

TEAM HEALTH HOLDINGS, INC. 2022 TERM LOAN B

0.70 248,211
Corporate

Jefferies Finance LLC/JFIN Co-Issuer Corp 5%

0.67 239,468
Corporate

CSC Holdings, LLC 5.375%

0.61 215,275
Corporate

Amneal Pharmaceuticals Llc 2023 Term Loan B

0.59 208,454
Corporate

Tenet Healthcare Corporation 6.25%

0.56 200,050
Corporate

OCI NV 6.7%

0.56 199,132
Corporate

Burford Capital Global Finance LLC 6.875%

0.55 197,228
Corporate

Jazz Securities Designated Activity Company 4.375%

0.55 195,825
Corporate

Ford Motor Credit Company LLC 5.113%

0.55 194,376
Corporate